Help us keep OnCuba alive The Itolizumab monoclonal antibody, a creation of the Cuban Center for Molecular Immunology (CIM) that has shown its value in patients infected with coronavirus, was officially approved for use against this disease by the Cuban regulatory authority. The Center for State Control of Medicines, Equipment and Medical Devices (CECMED) confirmed …